Alain Chariot's team has just published a study in EMBO Molecular Medicine shedding light on the unexpected role of the ...

Strengthened financial position through disciplined cost management, with a year-end 2025 cash position of $14.7 million and runway into ...

Androgenetic alopecia (AGA) is the most common form of hair loss, affecting 23–87% of the global population. It is driven by genetic predisposition ...

Iterion Therapeutics, a clinical-stage, biopharmaceutical company dedicated to advancing the treatment of Wnt-driven cancers, ...

Dental pulp injury caused by trauma or deep caries often leads to inflammation, tissue necrosis, and eventual loss of tooth ...

Expect to submit an Investigational New Drug application for SZN-8141 to FDA in the second half of 2026Scheduled to present retinal vascular ...

Preclinical research across multiple cancer types now shows that the NAD+ salvage pathway, the same biological mechanism ...

Researchers uncover how SMAD7 directly activates Wnt signaling to promote dental pulp stem cell regeneration CHINA, ...

Financing Expected to Fund Completion of Phase 2 Ovarian Cancer TrialFinancing Supports Acceleration Toward Pivotal Trial and CommercializationFinancing Structured as Non-Convertible Debt Financing ...

Strengthened financial position through disciplined cost management, with a year-end 2025 cash position of $14.7 million and runway into mid-2028Received FDA Fast Track designation for stenoparib, ena ...

The plausible mechanism pathway “could accelerate gene therapy/editing development,” analysts at William Blair said Thursday, while adding that additional clarity is needed. Individualized therapies ...